by GlobeNewsWire | Mar 7, 2016 | Globe Newswire
SANTA MONICA, Calif., March 07, 2016 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders, announced the change of its...
by GlobeNewsWire | Feb 17, 2016 | Globe Newswire
SANTA MONICA, Calif., Feb. 17, 2016 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders, announced the first convening of its...
by GlobeNewsWire | Feb 17, 2016 | Globe Newswire
SANTA MONICA, Calif., Feb. 17, 2016 (GLOBE NEWSWIRE) — Lightlake Therapeutics Inc. (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders, announced that it has changed the company...
by GlobeNewsWire | Jan 27, 2016 | Globe Newswire
NEW YORK, Jan. 27, 2016 (GLOBE NEWSWIRE) — Lightlake Therapeutics Inc. (“Lightlake”) (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use, addiction, and eating disorders, announced today that Adapt Pharma...
by GlobeNewsWire | Dec 23, 2015 | Globe Newswire
NEW YORK, Dec. 23, 2015 (GLOBE NEWSWIRE) — Lightlake Therapeutics Inc. (“Lightlake”) (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use, addiction, and eating disorders, announced today that an opioid...
